Exane Derivatives Biomarin Pharmaceutical Inc Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Exane Derivatives holds 1,473 shares of BMRN stock, worth $99,250. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,473

Previous 1,889 22.02%

Holding current value

$99,250

Previous $145,000 15.86%

% of portfolio

0.08%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$71.48 - $86.85 $29,735 - $36,129	-416 Reduced 22.02%	1,473 $122,000
Q1 2022 Apr 22, 2022	SELL	$74.28 - $92.69 $16,341 - $20,391	-220 Reduced 10.43%	1,889 $145,000
Q4 2021 Jan 28, 2022	SELL	$71.72 - $91.47 $47,837 - $61,010	-667 Reduced 24.03%	2,109 $186,000
Q3 2021 Oct 26, 2021	SELL	$74.77 - $85.47 $21,907 - $25,042	-293 Reduced 9.55%	2,776 $214,000
Q2 2021 Jul 28, 2021	BUY	$75.51 - $84.79 $17,593 - $19,756	233 Added 8.22%	3,069 $256,000
Q1 2021 Apr 30, 2021	BUY	$74.73 - $90.69 $73,085 - $88,694	978 Added 52.64%	2,836 $214,000
Q4 2020 Jan 27, 2021	BUY	$72.61 - $90.2 $82,049 - $101,926	1,130 Added 155.22%	1,858 $162,000
Q1 2020 Apr 17, 2020	SELL	$71.37 - $96.85 $11,776 - $15,980	-165 Reduced 18.48%	728 $61,000
Q3 2019 Oct 15, 2019	SELL	$67.4 - $85.11 $337 - $425	-5 Reduced 0.56%	893 $60,000
Q2 2019 Jul 12, 2019	BUY	$80.35 - $93.9 $80 - $93	1 Added 0.11%	898 $0
Q1 2019 Apr 24, 2019	BUY	$84.2 - $98.62 $36,206 - $42,406	430 Added 92.08%	897 $0
Q4 2018 Jan 31, 2019	BUY	$80.14 - $106.07 $36,383 - $48,155	454 Added 3492.31%	467 $39,000
Q3 2018 Oct 24, 2018	SELL	$93.92 - $105.72 $123,504 - $139,021	-1,315 Reduced 99.02%	13 $0
Q2 2018 Jul 19, 2018	SELL	$76.01 - $99.03 $2,660 - $3,466	-35 Reduced 2.57%	1,328 $0
Q1 2018 Apr 30, 2018	BUY	$77.67 - $92.63 $103,378 - $123,290	1,331 Added 4159.38%	1,363 $0
Q4 2017 Jan 29, 2018	SELL	$80.76 - $95.13 $11,306 - $13,318	-140 Reduced 81.4%	32 $0
Q3 2017 Oct 18, 2017	BUY	$80.6 - $94.95 $13,863 - $16,331	172	172 $0

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Biomarin Pharmaceutical Inc Transaction History